Skip to main content
PMC home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 1998 Jan;80(1):16–24.

Extended lymphadenectomy in gastric cancer: when, for whom and why.

D H Roukos 1
PMCID: PMC2502772  PMID: 9579122

Abstract

Although lymph node metastasis is a major prognostic factor in gastric cancer, the optimal extent of lymph node dissection still remains a subject of debate. The influence of extended D2 lymphadenectomy on morbidity and long-term survival is controversial. Reports from many Japanese and some Western institutions show similar morbidity and mortality rates for both limited D1 and extended D2 resections. However, the four available randomised trials show a significant increase in operative morbidity and mortality after a D2 resection. The authors of these trials believe that distal pancreaticosplenectomy is responsible for this increased morbidity and mortality and not the lymphadenectomy itself. Retrospective and prospective non-randomised studies show superior stage (II/IIIA) specific survival rates after D2 resections. However, these studies did not eliminate stage migration and randomised trials failed to show any survival advantage in favour of the D2 resection. Current data suggest that D2 resection is beneficial to the subgroup of patients with N1 or N2 disease undergoing potentially curative resection. However, Western studies that support D2 resection, fail to show any survival advantage for D2 resection in N2 patients, reporting a benefit only to N0 or N1 patients. In contrast, Japanese series report a large number of N2 long-term survivors. The question as to the possible beneficial effect of extended lymphadenectomy in gastric cancer is difficult and complex. D2 resection increases the potentially curative resection rate, at least in N2 patients, achieves a better locoregional tumour control and provides the only chance for cure among N2 patients since adjuvant treatment in gastric carcinoma has not yet been proved effective. However, all randomised comparisons warn of an increased risk after D2 resection. By avoiding pancreaticosplenectomy, however, the morbidity can be within acceptable limits. D2 gastrectomy seems to be the most attractive procedure in the surgical management of gastric cancer.

Full text

PDF
16

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akoh J. A., Macintyre I. M. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg. 1992 Apr;79(4):293–299. doi: 10.1002/bjs.1800790404. [DOI] [PubMed] [Google Scholar]
  2. Allum W. H., Powell D. J., McConkey C. C., Fielding J. W. Gastric cancer: a 25-year review. Br J Surg. 1989 Jun;76(6):535–540. doi: 10.1002/bjs.1800760604. [DOI] [PubMed] [Google Scholar]
  3. Baba H., Maehara Y., Takeuchi H., Inutsuka S., Okuyama T., Adachi Y., Akazawa K., Sugimachi K. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery. 1995 Feb;117(2):165–169. doi: 10.1016/s0039-6060(05)80080-7. [DOI] [PubMed] [Google Scholar]
  4. Bonenkamp J. J., Songun I., Hermans J., Sasako M., Welvaart K., Plukker J. T., van Elk P., Obertop H., Gouma D. J., Taat C. W. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995 Mar 25;345(8952):745–748. doi: 10.1016/s0140-6736(95)90637-1. [DOI] [PubMed] [Google Scholar]
  5. Bonenkamp J. J., van de Velde C. J. Lymph node dissection in gastric cancer. Br J Surg. 1995 Jul;82(7):867–869. doi: 10.1002/bjs.1800820703. [DOI] [PubMed] [Google Scholar]
  6. Bozzetti F., Bonfanti G., Morabito A., Bufalino R., Menotti V., Andreola S., Doci R., Gennari L. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet. 1986 Mar;162(3):229–234. [PubMed] [Google Scholar]
  7. Breaux J. R., Bringaze W., Chappuis C., Cohn I., Jr Adenocarcinoma of the stomach: a review of 35 years and 1,710 cases. World J Surg. 1990 Sep-Oct;14(5):580–586. doi: 10.1007/BF01658794. [DOI] [PubMed] [Google Scholar]
  8. Brennan M. F. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer. 1989 Nov 15;64(10):2063–2063. doi: 10.1002/1097-0142(19891115)64:10<2063::aid-cncr2820641015>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  9. Bunt A. M., Hermans J., Smit V. T., van de Velde C. J., Fleuren G. J., Bruijn J. A. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol. 1995 Jan;13(1):19–25. doi: 10.1200/JCO.1995.13.1.19. [DOI] [PubMed] [Google Scholar]
  10. Böttcher K., Becker K., Busch R., Roder J. D., Siewert J. R. Prognosefaktoren beim Magencarcinom. Ergebnisse einer uni- und multivariaten Analyse. Chirurg. 1992 Aug;63(8):656–661. [PubMed] [Google Scholar]
  11. Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg. 1984 Sep;119(9):1067–1072. doi: 10.1001/archsurg.1984.01390210063014. [DOI] [PubMed] [Google Scholar]
  12. Cady B., Rossi R. L., Silverman M. L., Piccione W., Heck T. A. Gastric adenocarcinoma. A disease in transition. Arch Surg. 1989 Mar;124(3):303–308. doi: 10.1001/archsurg.1989.01410030049009. [DOI] [PubMed] [Google Scholar]
  13. Candela F. C., Urmacher C., Brennan M. F. Comparison of the conventional method of lymph node staging with a comprehensive fat-clearing method for gastric adenocarcinoma. Cancer. 1990 Oct 15;66(8):1828–1832. doi: 10.1002/1097-0142(19901015)66:8<1828::aid-cncr2820660830>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  14. Cuschieri A., Fayers P., Fielding J., Craven J., Bancewicz J., Joypaul V., Cook P. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996 Apr 13;347(9007):995–999. doi: 10.1016/s0140-6736(96)90144-0. [DOI] [PubMed] [Google Scholar]
  15. Dent D. M., Madden M. V., Price S. K. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988 Feb;75(2):110–112. doi: 10.1002/bjs.1800750206. [DOI] [PubMed] [Google Scholar]
  16. Fass J., Hungs M., Reineke T., Nachtkamp J., Schumpelick V. Zur Frage der Prognoseverbesserung durch R1- und R2-Lymphadenektomie beim Magencarcinom. Chirurg. 1994 Oct;65(10):867–872. [PubMed] [Google Scholar]
  17. Feinstein A. R., Sosin D. M., Wells C. K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985 Jun 20;312(25):1604–1608. doi: 10.1056/NEJM198506203122504. [DOI] [PubMed] [Google Scholar]
  18. Fielding J. W. Gastric cancer: different diseases. Br J Surg. 1989 Dec;76(12):1227–1227. doi: 10.1002/bjs.1800761202. [DOI] [PubMed] [Google Scholar]
  19. Gall F. P., Hermanek P. New aspects in the surgical treatment of gastric carcinoma--a comparative study of 1636 patients operated on between 1969 and 1982. Eur J Surg Oncol. 1985 Sep;11(3):219–225. [PubMed] [Google Scholar]
  20. Gilbertsen V. A. Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a rort of 1,983 cases. Cancer. 1969 Jun;23(6):1305–1308. doi: 10.1002/1097-0142(196906)23:6<1305::aid-cncr2820230610>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  21. Hermanek P., Wittekind C. News of TNM and its use for classification of gastric cancer. World J Surg. 1995 Jul-Aug;19(4):491–495. doi: 10.1007/BF00294707. [DOI] [PubMed] [Google Scholar]
  22. Inokuchi K. Prolonged survival of gastric cancer patients on a specific adjuvant chemotherapy. Jpn J Surg. 1984 Sep;14(5):351–359. doi: 10.1007/BF02469540. [DOI] [PubMed] [Google Scholar]
  23. Irvin T. T., Bridger J. E. Gastric cancer: an audit of 122 consecutive cases and the results of R1 gastrectomy. Br J Surg. 1988 Feb;75(2):106–109. doi: 10.1002/bjs.1800750205. [DOI] [PubMed] [Google Scholar]
  24. Isozaki H., Okajima K., Kawashima Y., Yamada S., Nakata E., Nishimura J., Ichinona T. Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol. 1993 Aug;53(4):247–251. doi: 10.1002/jso.2930530412. [DOI] [PubMed] [Google Scholar]
  25. Jaehne J., Meyer H. J., Maschek H., Geerlings H., Burns E., Pichlmayr R. Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg. 1992 Mar;127(3):290–294. doi: 10.1001/archsurg.1992.01420030052010. [DOI] [PubMed] [Google Scholar]
  26. Jessup J. M. Is bigger better? J Clin Oncol. 1995 Jan;13(1):5–7. doi: 10.1200/JCO.1995.13.1.5. [DOI] [PubMed] [Google Scholar]
  27. Kampschöer G. H., Maruyama K., van de Velde C. J., Sasako M., Kinoshita T., Okabayashi K. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg. 1989 Sep;76(9):905–908. doi: 10.1002/bjs.1800760910. [DOI] [PubMed] [Google Scholar]
  28. Kodama Y., Sugimachi K., Soejima K., Matsusaka T., Inokuchi K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg. 1981 Mar;5(2):241–248. doi: 10.1007/BF01658301. [DOI] [PubMed] [Google Scholar]
  29. LAWRENCE W., Jr, MCNEER G. An analysis of the role of radical surgery for gastric cancer. Surg Gynecol Obstet. 1960 Dec;111:691–696. [PubMed] [Google Scholar]
  30. Lawrence W., Jr, Horsley J. S., 3rd "Extended" lymph node dissections for gastric cancer--is more better? J Surg Oncol. 1996 Feb;61(2):85–89. doi: 10.1002/(SICI)1096-9098(199602)61:2<85::AID-JSO1>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  31. Makino M., Moriwaki S., Yonekawa M., Oota M., Kimura O., Kaibara N. Prognostic significance of the number of metastatic lymph nodes in patients with gastric cancer. J Surg Oncol. 1991 May;47(1):12–16. doi: 10.1002/jso.2930470104. [DOI] [PubMed] [Google Scholar]
  32. Maruyama K., Okabayashi K., Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987 Aug;11(4):418–425. doi: 10.1007/BF01655804. [DOI] [PubMed] [Google Scholar]
  33. Maruyama K., Sasako M., Kinoshita T., Sano T., Katai H., Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg. 1995 Jul-Aug;19(4):532–536. doi: 10.1007/BF00294714. [DOI] [PubMed] [Google Scholar]
  34. McCulloch P. G., Ochiai A., O'Dowd G. M., Nash J. R., Sasako M., Hirohashi S. Comparison of the molecular genetics of c-erb-B2 and p53 expression in stomach cancer in Britain and Japan. Cancer. 1995 Feb 15;75(4):920–925. doi: 10.1002/1097-0142(19950215)75:4<920::aid-cncr2820750405>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  35. Meyers W. C., Damiano R. J., Jr, Rotolo F. S., Postlethwait R. W. Adenocarcinoma of the stomach. Changing patterns over the last 4 decades. Ann Surg. 1987 Jan;205(1):1–8. doi: 10.1097/00000658-198701000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Milewski P. J., Bancewicz J. Improving the results of treating gastric cancer. BMJ. 1989 Jul 29;299(6694):278–279. doi: 10.1136/bmj.299.6694.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mine M., Majima S., Harada M., Etani S. End results of gastrectomy for gastric cancer: effect of extensive lymph node dissection. Surgery. 1970 Nov;68(5):753–758. [PubMed] [Google Scholar]
  38. Nakajima T., Nishi M. Surgery and adjuvant chemotherapy for gastric cancer. Hepatogastroenterology. 1989 Apr;36(2):79–85. [PubMed] [Google Scholar]
  39. Natsugoe S., Aiko T., Shimazu H. A detailed histological study on occult metastasis of the lymph nodes. Jpn J Surg. 1991 Sep;21(5):528–532. doi: 10.1007/BF02470990. [DOI] [PubMed] [Google Scholar]
  40. Noguchi Y., Imada T., Matsumoto A., Coit D. G., Brennan M. F. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer. 1989 Nov 15;64(10):2053–2062. doi: 10.1002/1097-0142(19891115)64:10<2053::aid-cncr2820641014>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  41. Okajima K., Isozaki H. Splenectomy for treatment of gastric cancer: Japanese experience. World J Surg. 1995 Jul-Aug;19(4):537–540. doi: 10.1007/BF00294715. [DOI] [PubMed] [Google Scholar]
  42. Okusa T., Nakane Y., Boku T., Takada H., Yamamura M., Hioki K., Yamamoto M. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet. 1990 Jun;170(6):488–494. [PubMed] [Google Scholar]
  43. Pacelli F., Doglietto G. B., Bellantone R., Alfieri S., Sgadari A., Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg. 1993 Sep;80(9):1153–1156. doi: 10.1002/bjs.1800800930. [DOI] [PubMed] [Google Scholar]
  44. Robertson C. S., Chung S. C., Woods S. D., Griffin S. M., Raimes S. A., Lau J. T., Li A. K. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg. 1994 Aug;220(2):176–182. doi: 10.1097/00000658-199408000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Roder J. D., Böttcher K., Siewert J. R., Busch R., Hermanek P., Meyer H. J. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer. 1993 Oct 1;72(7):2089–2097. doi: 10.1002/1097-0142(19931001)72:7<2089::aid-cncr2820720706>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  46. Rohde H., Gebbensleben B., Bauer P., Stützer H., Zieschang J. Has there been any improvement in the staging of gastric cancer? Findings from the German Gastric Cancer TNM Study Group. Cancer. 1989 Dec 15;64(12):2465–2481. doi: 10.1002/1097-0142(19891215)64:12<2465::aid-cncr2820641212>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  47. Roukos D. H., Hottenrott C., Lorenz M., Koutsogiorgas-Couchell S. A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach. An analysis of early results and long-term survival. J Cancer Res Clin Oncol. 1990;116(3):307–313. doi: 10.1007/BF01612909. [DOI] [PubMed] [Google Scholar]
  48. Roukos D., Schmidt-Mathiesen A., Encke A. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification. Surg Oncol. 1995;4(6):323–332. doi: 10.1016/s0960-7404(10)80045-3. [DOI] [PubMed] [Google Scholar]
  49. Sasako M., McCulloch P., Kinoshita T., Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995 Mar;82(3):346–351. doi: 10.1002/bjs.1800820321. [DOI] [PubMed] [Google Scholar]
  50. Sendler A., Dittler H. J., Feussner H., Nekarda H., Bollschweiler E., Fink U., Helmberger H., Höfler H., Siewert J. R. Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg. 1995 Jul-Aug;19(4):501–508. doi: 10.1007/BF00294710. [DOI] [PubMed] [Google Scholar]
  51. Shiu M. H., Moore E., Sanders M., Huvos A., Freedman B., Goodbold J., Chaiyaphruk S., Wesdorp R., Brennan M. F. Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis. Arch Surg. 1987 Nov;122(11):1347–1351. doi: 10.1001/archsurg.1987.01400230135024. [DOI] [PubMed] [Google Scholar]
  52. Siewert J. R., Böttcher K., Roder J. D., Busch R., Hermanek P., Meyer H. J. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg. 1993 Aug;80(8):1015–1018. doi: 10.1002/bjs.1800800829. [DOI] [PubMed] [Google Scholar]
  53. Siewert J. R., Kestlmeier R., Busch R., Böttcher K., Roder J. D., Müller J., Fellbaum C., Höfler H. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg. 1996 Aug;83(8):1144–1147. doi: 10.1002/bjs.1800830836. [DOI] [PubMed] [Google Scholar]
  54. Smith J. W., Shiu M. H., Kelsey L., Brennan M. F. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg. 1991 Dec;126(12):1469–1473. doi: 10.1001/archsurg.1991.01410360039007. [DOI] [PubMed] [Google Scholar]
  55. Sue-Ling H. M., Johnston D., Martin I. G., Dixon M. F., Lansdown M. R., McMahon M. J., Axon A. T. Gastric cancer: a curable disease in Britain. BMJ. 1993 Sep 4;307(6904):591–596. doi: 10.1136/bmj.307.6904.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wanebo H. J., Kennedy B. J., Chmiel J., Steele G., Jr, Winchester D., Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg. 1993 Nov;218(5):583–592. doi: 10.1097/00000658-199321850-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wilkinson E. J., Hause L. Probability in lymph node sectioning. Cancer. 1974 May;33(5):1269–1274. doi: 10.1002/1097-0142(197405)33:5<1269::aid-cncr2820330512>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES